恆指受制22,200曾倒跌 舜宇倒跌4% 藥明生物續漲8%
據報美國總統拜登或於周內宣布取消部分中國貨進口關稅。美股期貨全面反覆續彈0.3%-0.5%。此外,財新中國5月服務業PMI意外重現擴張,由前值41.4,續升至54.5,遠勝市場預期49.6。亞太股市今早普遍造好,尤其是韓股曾急彈1.9%,現升幅收窄至1.1%報2,325;餘下升幅現均少於1%,其中日經續升0.6%報26,316。然而,滬深及台股倒跌,台灣加權指數蒸發曾急彈1.9%所有升幅,倒跌0.6%報14,129,連跌第六天。
恆指扭三連吐,今早曾反彈368點或1.7%至22,198遇阻,曾倒跌22點低見21,807,現報21,919,反彈89點或0.4%,成交額668億元。
藍籌股個別發展。舜宇(02382.HK)四連跌,早段曾彈3.8%至124元無以為繼,掉頭低見113元,現報114.7元,倒跌4%。
比亞迪(01211.HK)、農夫山泉(09633.HK)、龍湖(00960.HK)、海底撈(06862.HK)、美團(03690.HK)及小米(01810.HK)也倒跌逾1%-2%,後兩者沽壓最大,報197.8元及13.48元,倒跌1.6%及2.6%。
然而,市傳正爭取美國撤銷貿易警告的藥明生物(02269.HK)曾急漲10%高見85.5元,現報83.8元,續升8%。阿里健康(00241.HK)升5.7%報5.79元。
創科(00669.HK)續升3%報87.8元。信義光能(00968.HK)及宏橋(01378.HK)彈逾2%。此外,銀行股普遍向好,其中匯控(00005.HK)升1%報51.75元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.